Skip to main content
Top
Published in: Diabetologia 11/2016

01-11-2016 | Article

The effect of different volumes of high-intensity interval training on proinsulin in participants with the metabolic syndrome: a randomised trial

Authors: Joyce S. Ramos, Lance C. Dalleck, Fabio Borrani, Alistair R. Mallard, Bronwyn Clark, Shelley E. Keating, Robert G. Fassett, Jeff S. Coombes

Published in: Diabetologia | Issue 11/2016

Login to get access

Abstract

Aims/hypothesis

The continuous demand for insulin in the face of insulin resistance, coupled with the glucolipotoxic environment associated with the metabolic syndrome (MetS), adversely affects the quality of insulin produced and secreted by the pancreatic beta cells. This is depicted by increased circulating intact proinsulin concentration, which is associated with increased MetS severity and risk of cardiovascular (CV) mortality. High-intensity interval training (HIIT) has been shown to reduce insulin resistance and other CV disease risk factors to a greater degree than moderate-intensity continuous training (MICT). We therefore aimed to investigate the impact of MICT and different volumes of HIIT on circulating intact proinsulin concentration.

Methods

This was a substudy of the ‘Exercise in prevention of Metabolic Syndrome’ (EX-MET) multicentre trial. Sixty-six individuals with MetS were randomised to 16 weeks of: (1) MICT (n = 21, 30 min at 60–70% peak heart rate [HRpeak], five times/week); (2) 4HIIT (n = 22, 4 × 4 min bouts at 85–95% HRpeak, interspersed with 3 min of active recovery at 50–70% HRpeak, three times/week); or (3) 1HIIT (n = 23, 1 × 4 min bout at 85–95% HRpeak, three times/week). A subanalysis investigated the differential impact of these training programmes on intact proinsulin concentration in MetS individuals with type 2 diabetes (MICT, n = 6; 4HIIT, n = 9; 1HIIT, n = 12) and without type 2 diabetes (MICT, n = 15; 4HIIT, n = 13; 1HIIT, n = 11). Intact proinsulin, insulin and C-peptide concentrations were measured in duplicate via ELISA, following a 12 h fast, before and after the exercise programme. Fasting intact proinsulin concentration was also expressed relative to insulin and C-peptide concentrations.

Results

Following the exercise training, there were no significant (p > 0.05) changes in fasting intact proinsulin concentration indices in all participants (pre- vs post-programme proinsulin, proinsulin:insulin, proinsulin:C-peptide: MICT 19% decrease, 6% increase, 4% increase; 4HIIT 19% decrease, 8% decrease, 11% decrease; 1HIIT 34% increase, 49% increase, 36% increase). In participants who did not have type 2 diabetes, only 4HIIT significantly (p < 0.05) reduced fasting intact proinsulin concentration indices from pre to post intervention (pre- vs post-programme proinsulin, proinsulin:insulin, proinsulin:C-peptide: 4HIIT 32% decrease, 26% decrease, 32% decrease, p < 0.05; 1HIIT, 14% increase, 32% increase, 16% increase, p > 0.05; MICT 27% decrease, 17% decrease, 11% decrease), with a group × time interaction effect, indicating a greater reduction in intact proinsulin indices following 4HIIT compared with MICT and 1HIIT. There were no significant (p > 0.05) changes in intact proinsulin concentration indices in participants with type 2 diabetes.

Conclusions/interpretation

Higher-volume HIIT (4HIIT) improved insulin quality in MetS participants without type 2 diabetes.

Trial registration:

ClinicalTrials.gov NCT01676870

Funding:

The study was funded by the Norwegian University of Science and Technology and from an unrestricted research grant from the Coca-Cola company. Funding for the collection of physical activity data was derived from a ‘UQ New Staff Start Up’ grant awarded to B. Clark.
Appendix
Available only for authorised users
Literature
1.
go back to reference Grundy SM, Brewer HB Jr, Cleeman JI, Smith SC Jr, Lenfant C (2004) Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Arterioscler Thromb Vasc Biol 24:e13–e18CrossRefPubMed Grundy SM, Brewer HB Jr, Cleeman JI, Smith SC Jr, Lenfant C (2004) Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Arterioscler Thromb Vasc Biol 24:e13–e18CrossRefPubMed
2.
go back to reference Malin SK, Finnegan S, Fealy CE, Filion J, Rocco MB, Kirwan JP (2014) beta-Cell dysfunction is associated with metabolic syndrome severity in adults. Metab Syndr Relat Disord 12:79–85CrossRefPubMedPubMedCentral Malin SK, Finnegan S, Fealy CE, Filion J, Rocco MB, Kirwan JP (2014) beta-Cell dysfunction is associated with metabolic syndrome severity in adults. Metab Syndr Relat Disord 12:79–85CrossRefPubMedPubMedCentral
3.
go back to reference Poitout V, Robertson RP (2008) Glucolipotoxicity: fuel excess and beta-cell dysfunction. Endocr Rev 29:351–366CrossRefPubMed Poitout V, Robertson RP (2008) Glucolipotoxicity: fuel excess and beta-cell dysfunction. Endocr Rev 29:351–366CrossRefPubMed
4.
go back to reference Rhodes CJ, Alarcon C (1994) What beta-cell defect could lead to hyperproinsulinemia in NIDDM? Some clues from recent advances made in understanding the proinsulin-processing mechanism. Diabetes 43:511–517CrossRefPubMed Rhodes CJ, Alarcon C (1994) What beta-cell defect could lead to hyperproinsulinemia in NIDDM? Some clues from recent advances made in understanding the proinsulin-processing mechanism. Diabetes 43:511–517CrossRefPubMed
5.
go back to reference Alarcon C, Leahy JL, Schuppin GT, Rhodes CJ (1995) Increased secretory demand rather than a defect in the proinsulin conversion mechanism causes hyperproinsulinemia in a glucose-infusion rat model of non-insulin-dependent diabetes mellitus. J Clin Invest 95:1032–1039CrossRefPubMedPubMedCentral Alarcon C, Leahy JL, Schuppin GT, Rhodes CJ (1995) Increased secretory demand rather than a defect in the proinsulin conversion mechanism causes hyperproinsulinemia in a glucose-infusion rat model of non-insulin-dependent diabetes mellitus. J Clin Invest 95:1032–1039CrossRefPubMedPubMedCentral
6.
go back to reference Pfutzner A, Forst T (2011) Elevated intact proinsulin levels are indicative of Beta-cell dysfunction, insulin resistance, and cardiovascular risk: impact of the antidiabetic agent pioglitazone. J Diabetes Sci Technol 5:784–793CrossRefPubMedPubMedCentral Pfutzner A, Forst T (2011) Elevated intact proinsulin levels are indicative of Beta-cell dysfunction, insulin resistance, and cardiovascular risk: impact of the antidiabetic agent pioglitazone. J Diabetes Sci Technol 5:784–793CrossRefPubMedPubMedCentral
7.
go back to reference Cersosimo E, Solis-Herrera C, Trautmann ME, Malloy J, Triplitt CL (2014) Assessment of pancreatic beta-cell function: review of methods and clinical applications. Curr Diabetes Rev 10:2–42CrossRefPubMedPubMedCentral Cersosimo E, Solis-Herrera C, Trautmann ME, Malloy J, Triplitt CL (2014) Assessment of pancreatic beta-cell function: review of methods and clinical applications. Curr Diabetes Rev 10:2–42CrossRefPubMedPubMedCentral
8.
go back to reference Vangipurapu J, Stancakova A, Kuulasmaa T, Kuusisto J, Laakso M (2015) Both fasting and glucose-stimulated proinsulin levels predict hyperglycemia and incident type 2 diabetes: a population-based study of 9,396 finnish men. PLoS One 10:e0124028CrossRefPubMedPubMedCentral Vangipurapu J, Stancakova A, Kuulasmaa T, Kuusisto J, Laakso M (2015) Both fasting and glucose-stimulated proinsulin levels predict hyperglycemia and incident type 2 diabetes: a population-based study of 9,396 finnish men. PLoS One 10:e0124028CrossRefPubMedPubMedCentral
9.
go back to reference Alssema M, Dekker JM, Nijpels G, Stehouwer CD, Bouter LM, Heine RJ (2005) Proinsulin concentration is an independent predictor of all-cause and cardiovascular mortality: an 11-year follow-up of the Hoorn Study. Diabetes Care 28:860–865CrossRefPubMed Alssema M, Dekker JM, Nijpels G, Stehouwer CD, Bouter LM, Heine RJ (2005) Proinsulin concentration is an independent predictor of all-cause and cardiovascular mortality: an 11-year follow-up of the Hoorn Study. Diabetes Care 28:860–865CrossRefPubMed
10.
go back to reference Zethelius B, Byberg L, Hales CN, Lithell H, Berne C (2002) Proinsulin is an independent predictor of coronary heart disease: report from a 27-year follow-up study. Circulation 105:2153–2158CrossRefPubMed Zethelius B, Byberg L, Hales CN, Lithell H, Berne C (2002) Proinsulin is an independent predictor of coronary heart disease: report from a 27-year follow-up study. Circulation 105:2153–2158CrossRefPubMed
11.
go back to reference Haffner SM, Mykkanen L, Valdez RA et al (1994) Disproportionately increased proinsulin levels are associated with the insulin resistance syndrome. J Clin Endocrinol Metab 79:1806–1810PubMed Haffner SM, Mykkanen L, Valdez RA et al (1994) Disproportionately increased proinsulin levels are associated with the insulin resistance syndrome. J Clin Endocrinol Metab 79:1806–1810PubMed
12.
go back to reference Blair SN, Kampert JB, Kohl HW 3rd et al (1996) Influences of cardiorespiratory fitness and other precursors on cardiovascular disease and all-cause mortality in men and women. JAMA 276:205–210CrossRefPubMed Blair SN, Kampert JB, Kohl HW 3rd et al (1996) Influences of cardiorespiratory fitness and other precursors on cardiovascular disease and all-cause mortality in men and women. JAMA 276:205–210CrossRefPubMed
13.
go back to reference Pattyn N, Cornelissen VA, Eshghi SR, Vanhees L (2013) The effect of exercise on the cardiovascular risk factors constituting the metabolic syndrome: a meta-analysis of controlled trials. Sports Med (Auckland, NZ) 43:121–133CrossRef Pattyn N, Cornelissen VA, Eshghi SR, Vanhees L (2013) The effect of exercise on the cardiovascular risk factors constituting the metabolic syndrome: a meta-analysis of controlled trials. Sports Med (Auckland, NZ) 43:121–133CrossRef
14.
go back to reference Bateman LA, Slentz CA, Willis LH et al (2011) Comparison of aerobic versus resistance exercise training effects on metabolic syndrome (from the Studies of a Targeted Risk Reduction Intervention Through Defined Exercise - STRRIDE-AT/RT). Am J Cardiol 108:838–844CrossRefPubMedPubMedCentral Bateman LA, Slentz CA, Willis LH et al (2011) Comparison of aerobic versus resistance exercise training effects on metabolic syndrome (from the Studies of a Targeted Risk Reduction Intervention Through Defined Exercise - STRRIDE-AT/RT). Am J Cardiol 108:838–844CrossRefPubMedPubMedCentral
15.
go back to reference Johnson JL, Slentz CA, Houmard JA et al (2007) Exercise training amount and intensity effects on metabolic syndrome (from Studies of a Targeted Risk Reduction Intervention through Defined Exercise). Am J Cardiol 100:1759–1766CrossRefPubMedPubMedCentral Johnson JL, Slentz CA, Houmard JA et al (2007) Exercise training amount and intensity effects on metabolic syndrome (from Studies of a Targeted Risk Reduction Intervention through Defined Exercise). Am J Cardiol 100:1759–1766CrossRefPubMedPubMedCentral
16.
go back to reference Trost SG, Owen N, Bauman AE, Sallis JF, Brown W (2002) Correlates of adults’ participation in physical activity: review and update. Med Sci Sports Exerc 34:1996–2001CrossRefPubMed Trost SG, Owen N, Bauman AE, Sallis JF, Brown W (2002) Correlates of adults’ participation in physical activity: review and update. Med Sci Sports Exerc 34:1996–2001CrossRefPubMed
17.
go back to reference Weston KS, Wisloff U, Coombes JS (2014) High-intensity interval training in patients with lifestyle-induced cardiometabolic disease: a systematic review and meta-analysis. Br J Sports Med 48:1227–1234CrossRefPubMed Weston KS, Wisloff U, Coombes JS (2014) High-intensity interval training in patients with lifestyle-induced cardiometabolic disease: a systematic review and meta-analysis. Br J Sports Med 48:1227–1234CrossRefPubMed
18.
go back to reference Jelleyman C, Yates T, O’Donovan G et al (2015) The effects of high-intensity interval training on glucose regulation and insulin resistance: a meta-analysis. Obes Rev 16:942–961CrossRefPubMed Jelleyman C, Yates T, O’Donovan G et al (2015) The effects of high-intensity interval training on glucose regulation and insulin resistance: a meta-analysis. Obes Rev 16:942–961CrossRefPubMed
19.
go back to reference Tjonna AE, Leinan IM, Bartnes AT et al (2013) Low- and high-volume of intensive endurance training significantly improves maximal oxygen uptake after 10-weeks of training in healthy men. PLoS One 8:e65382CrossRefPubMedPubMedCentral Tjonna AE, Leinan IM, Bartnes AT et al (2013) Low- and high-volume of intensive endurance training significantly improves maximal oxygen uptake after 10-weeks of training in healthy men. PLoS One 8:e65382CrossRefPubMedPubMedCentral
20.
go back to reference Solomon TP, Malin SK, Karstoft K et al (2015) Association between cardiorespiratory fitness and the determinants of glycemic control across the entire glucose tolerance continuum. Diabetes Care 38:921–929CrossRefPubMedPubMedCentral Solomon TP, Malin SK, Karstoft K et al (2015) Association between cardiorespiratory fitness and the determinants of glycemic control across the entire glucose tolerance continuum. Diabetes Care 38:921–929CrossRefPubMedPubMedCentral
21.
go back to reference Ramos JS, Dalleck LC, Ramos MV et al (2016) Twelve minutes/week of high-intensity exercise significantly decreases aortic reservoir pressure in individuals with metabolic syndrome. J Hypertens (in press) Ramos JS, Dalleck LC, Ramos MV et al (2016) Twelve minutes/week of high-intensity exercise significantly decreases aortic reservoir pressure in individuals with metabolic syndrome. J Hypertens (in press)
24.
go back to reference American College of Sports Medicine (2014) ACSM’s guidelines for exercise testing and prescription. Lippincott Williams & Wilkins, Baltimore American College of Sports Medicine (2014) ACSM’s guidelines for exercise testing and prescription. Lippincott Williams & Wilkins, Baltimore
25.
go back to reference Ryan CG, Grant PM, Tigbe WW, Granat MH (2006) The validity and reliability of a novel activity monitor as a measure of walking. Br J Sports Med 40:779–784CrossRefPubMedPubMedCentral Ryan CG, Grant PM, Tigbe WW, Granat MH (2006) The validity and reliability of a novel activity monitor as a measure of walking. Br J Sports Med 40:779–784CrossRefPubMedPubMedCentral
26.
go back to reference Healy GN, Winkler EA, Owen N, Anuradha S, Dunstan DW (2015) Replacing sitting time with standing or stepping: associations with cardio-metabolic risk biomarkers. Eur Heart J 36:2643–2649CrossRefPubMed Healy GN, Winkler EA, Owen N, Anuradha S, Dunstan DW (2015) Replacing sitting time with standing or stepping: associations with cardio-metabolic risk biomarkers. Eur Heart J 36:2643–2649CrossRefPubMed
27.
go back to reference Torjesen PA, Birkeland KI, Anderssen SA, Hjermann I, Holme I, Urdal P (1997) Lifestyle changes may reverse development of the insulin resistance syndrome. Oslo Diet Exerc Study: Randomized Trial. Diabetes Care 20:26–31 Torjesen PA, Birkeland KI, Anderssen SA, Hjermann I, Holme I, Urdal P (1997) Lifestyle changes may reverse development of the insulin resistance syndrome. Oslo Diet Exerc Study: Randomized Trial. Diabetes Care 20:26–31
28.
go back to reference Wajchenberg BL (2010) Clinical approaches to preserve beta-cell function in diabetes. Adv Exp Med Biol 654:515–535CrossRefPubMed Wajchenberg BL (2010) Clinical approaches to preserve beta-cell function in diabetes. Adv Exp Med Biol 654:515–535CrossRefPubMed
29.
go back to reference Lira VA, Benton CR, Yan Z, Bonen A (2010) PGC-1alpha regulation by exercise training and its influences on muscle function and insulin sensitivity. Am J Phys Endocrinol Metab 299:E145–E161 Lira VA, Benton CR, Yan Z, Bonen A (2010) PGC-1alpha regulation by exercise training and its influences on muscle function and insulin sensitivity. Am J Phys Endocrinol Metab 299:E145–E161
30.
go back to reference Benton CR, Nickerson JG, Lally J et al (2008) Modest PGC-1alpha overexpression in muscle in vivo is sufficient to increase insulin sensitivity and palmitate oxidation in subsarcolemmal, not intermyofibrillar, mitochondria. J Biol Chem 283:4228–4240CrossRefPubMed Benton CR, Nickerson JG, Lally J et al (2008) Modest PGC-1alpha overexpression in muscle in vivo is sufficient to increase insulin sensitivity and palmitate oxidation in subsarcolemmal, not intermyofibrillar, mitochondria. J Biol Chem 283:4228–4240CrossRefPubMed
31.
go back to reference Leloup C, Tourrel-Cuzin C, Magnan C et al (2009) Mitochondrial reactive oxygen species are obligatory signals for glucose-induced insulin secretion. Diabetes 58:673–681CrossRefPubMedPubMedCentral Leloup C, Tourrel-Cuzin C, Magnan C et al (2009) Mitochondrial reactive oxygen species are obligatory signals for glucose-induced insulin secretion. Diabetes 58:673–681CrossRefPubMedPubMedCentral
33.
go back to reference Robertson RP, Harmon J, Tran PO, Tanaka Y, Takahashi H (2003) Glucose toxicity in beta-cells: type 2 diabetes, good radicals gone bad, and the glutathione connection. Diabetes 52:581–587CrossRefPubMed Robertson RP, Harmon J, Tran PO, Tanaka Y, Takahashi H (2003) Glucose toxicity in beta-cells: type 2 diabetes, good radicals gone bad, and the glutathione connection. Diabetes 52:581–587CrossRefPubMed
34.
go back to reference Malhotra JD, Kaufman RJ (2007) Endoplasmic reticulum stress and oxidative stress: a vicious cycle or a double-edged sword? Antioxid Redox Signal 9:2277–2293CrossRefPubMed Malhotra JD, Kaufman RJ (2007) Endoplasmic reticulum stress and oxidative stress: a vicious cycle or a double-edged sword? Antioxid Redox Signal 9:2277–2293CrossRefPubMed
35.
go back to reference Tjonna AE, Lee SJ, Rognmo O et al (2008) Aerobic interval training versus continuous moderate exercise as a treatment for the metabolic syndrome: a pilot study. Circulation 118:346–354CrossRefPubMedPubMedCentral Tjonna AE, Lee SJ, Rognmo O et al (2008) Aerobic interval training versus continuous moderate exercise as a treatment for the metabolic syndrome: a pilot study. Circulation 118:346–354CrossRefPubMedPubMedCentral
36.
go back to reference Hood MS, Little JP, Tarnopolsky MA, Myslik F, Gibala MJ (2011) Low-volume interval training improves muscle oxidative capacity in sedentary adults. Med Sci Sports Exerc 43:1849–1856CrossRefPubMed Hood MS, Little JP, Tarnopolsky MA, Myslik F, Gibala MJ (2011) Low-volume interval training improves muscle oxidative capacity in sedentary adults. Med Sci Sports Exerc 43:1849–1856CrossRefPubMed
37.
go back to reference Burgomaster KA, Howarth KR, Phillips SM et al (2008) Similar metabolic adaptations during exercise after low volume sprint interval and traditional endurance training in humans. J Physiol 586:151–160CrossRefPubMed Burgomaster KA, Howarth KR, Phillips SM et al (2008) Similar metabolic adaptations during exercise after low volume sprint interval and traditional endurance training in humans. J Physiol 586:151–160CrossRefPubMed
38.
go back to reference Little JP, Gillen JB, Percival ME et al (2011) Low-volume high-intensity interval training reduces hyperglycemia and increases muscle mitochondrial capacity in patients with type 2 diabetes. J Appl Physiol 111:1554–1560CrossRefPubMed Little JP, Gillen JB, Percival ME et al (2011) Low-volume high-intensity interval training reduces hyperglycemia and increases muscle mitochondrial capacity in patients with type 2 diabetes. J Appl Physiol 111:1554–1560CrossRefPubMed
39.
40.
go back to reference Ramos JS, Dalleck LC, Tjonna AE, Beetham KS, Coombes JS (2015) The impact of high-intensity interval training versus moderate-intensity continuous training on vascular function: a systematic review and meta-analysis. Sports Med (Auckland, NZ) 45:679–692CrossRef Ramos JS, Dalleck LC, Tjonna AE, Beetham KS, Coombes JS (2015) The impact of high-intensity interval training versus moderate-intensity continuous training on vascular function: a systematic review and meta-analysis. Sports Med (Auckland, NZ) 45:679–692CrossRef
41.
go back to reference Madsen SM, Thorup AC, Overgaard K, Bjerre M, Jeppesen PB (2015) Functional and structural vascular adaptations following 8 weeks of low volume high intensity interval training in lower leg of type 2 diabetes patients and individuals at high risk of metabolic syndrome. Arch Physiol Biochem 121:178–186CrossRefPubMed Madsen SM, Thorup AC, Overgaard K, Bjerre M, Jeppesen PB (2015) Functional and structural vascular adaptations following 8 weeks of low volume high intensity interval training in lower leg of type 2 diabetes patients and individuals at high risk of metabolic syndrome. Arch Physiol Biochem 121:178–186CrossRefPubMed
42.
go back to reference Madsen SM, Thorup AC, Bjerre M, Jeppesen PB (2015) Does 8 weeks of strenuous bicycle exercise improve diabetes-related inflammatory cytokines and free fatty acids in type 2 diabetes patients and individuals at high-risk of metabolic syndrome? Arch Physiol Biochem 121:129–138CrossRefPubMed Madsen SM, Thorup AC, Bjerre M, Jeppesen PB (2015) Does 8 weeks of strenuous bicycle exercise improve diabetes-related inflammatory cytokines and free fatty acids in type 2 diabetes patients and individuals at high-risk of metabolic syndrome? Arch Physiol Biochem 121:129–138CrossRefPubMed
43.
go back to reference Malin SK, Solomon TP, Blaszczak A, Finnegan S, Filion J, Kirwan JP (2013) Pancreatic beta-cell function increases in a linear dose-response manner following exercise training in adults with prediabetes. Am J Phys Endocrinol Metab 305:E1248–E1254CrossRef Malin SK, Solomon TP, Blaszczak A, Finnegan S, Filion J, Kirwan JP (2013) Pancreatic beta-cell function increases in a linear dose-response manner following exercise training in adults with prediabetes. Am J Phys Endocrinol Metab 305:E1248–E1254CrossRef
44.
go back to reference Koranyi LI, Bourey RE, Slentz CA, Holloszy JO, Permutt MA (1991) Coordinate reduction of rat pancreatic islet glucokinase and proinsulin mRNA by exercise training. Diabetes 40:401–404CrossRefPubMed Koranyi LI, Bourey RE, Slentz CA, Holloszy JO, Permutt MA (1991) Coordinate reduction of rat pancreatic islet glucokinase and proinsulin mRNA by exercise training. Diabetes 40:401–404CrossRefPubMed
45.
46.
go back to reference Dube JJ, Allison KF, Rousson V, Goodpaster BH, Amati F (2012) Exercise dose and insulin sensitivity: relevance for diabetes prevention. Med Sci Sports Exerc 44:793–799CrossRefPubMedPubMedCentral Dube JJ, Allison KF, Rousson V, Goodpaster BH, Amati F (2012) Exercise dose and insulin sensitivity: relevance for diabetes prevention. Med Sci Sports Exerc 44:793–799CrossRefPubMedPubMedCentral
47.
go back to reference Church TS, Blair SN, Cocreham S et al (2010) Effects of aerobic and resistance training on hemoglobin A1c levels in patients with type 2 diabetes: a randomized controlled trial. Jama 304:2253–2262CrossRefPubMedPubMedCentral Church TS, Blair SN, Cocreham S et al (2010) Effects of aerobic and resistance training on hemoglobin A1c levels in patients with type 2 diabetes: a randomized controlled trial. Jama 304:2253–2262CrossRefPubMedPubMedCentral
48.
go back to reference Madsen SM, Thorup AC, Overgaard K, Jeppesen PB (2015) High intensity interval training improves glycaemic control and pancreatic beta cell function of type 2 diabetes patients. PLoS One 10, e0133286CrossRefPubMedPubMedCentral Madsen SM, Thorup AC, Overgaard K, Jeppesen PB (2015) High intensity interval training improves glycaemic control and pancreatic beta cell function of type 2 diabetes patients. PLoS One 10, e0133286CrossRefPubMedPubMedCentral
49.
go back to reference Mitranun W, Deerochanawong C, Tanaka H, Suksom D (2014) Continuous vs interval training on glycemic control and macro- and microvascular reactivity in type 2 diabetic patients. Scand J Med Sci Sports 24:e69–e76CrossRefPubMed Mitranun W, Deerochanawong C, Tanaka H, Suksom D (2014) Continuous vs interval training on glycemic control and macro- and microvascular reactivity in type 2 diabetic patients. Scand J Med Sci Sports 24:e69–e76CrossRefPubMed
50.
go back to reference Malin SK, Kirwan JP (2012) Fasting hyperglycaemia blunts the reversal of impaired glucose tolerance after exercise training in obese older adults. Diabetes Obes Metab 14:835–841CrossRefPubMedPubMedCentral Malin SK, Kirwan JP (2012) Fasting hyperglycaemia blunts the reversal of impaired glucose tolerance after exercise training in obese older adults. Diabetes Obes Metab 14:835–841CrossRefPubMedPubMedCentral
51.
go back to reference Malin SK, Braun B (2016) Impact of Metformin on exercise-induced metabolic adaptations to lower type 2 diabetes risk. Exerc Sport Sci Rev 44:4–11CrossRefPubMed Malin SK, Braun B (2016) Impact of Metformin on exercise-induced metabolic adaptations to lower type 2 diabetes risk. Exerc Sport Sci Rev 44:4–11CrossRefPubMed
52.
go back to reference Malin SK, Gerber R, Chipkin SR, Braun B (2012) Independent and combined effects of exercise training and metformin on insulin sensitivity in individuals with prediabetes. Diabetes Care 35:131–136CrossRefPubMed Malin SK, Gerber R, Chipkin SR, Braun B (2012) Independent and combined effects of exercise training and metformin on insulin sensitivity in individuals with prediabetes. Diabetes Care 35:131–136CrossRefPubMed
53.
go back to reference Karstoft K, Winding K, Knudsen SH et al (2014) Mechanisms behind the superior effects of interval vs continuous training on glycaemic control in individuals with type 2 diabetes: a randomised controlled trial. Diabetologia 57:2081–2093CrossRefPubMed Karstoft K, Winding K, Knudsen SH et al (2014) Mechanisms behind the superior effects of interval vs continuous training on glycaemic control in individuals with type 2 diabetes: a randomised controlled trial. Diabetologia 57:2081–2093CrossRefPubMed
54.
go back to reference Krotkiewski M, Lonnroth P, Mandroukas K et al (1985) The effects of physical training on insulin secretion and effectiveness and on glucose metabolism in obesity and type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 28:881–890CrossRefPubMed Krotkiewski M, Lonnroth P, Mandroukas K et al (1985) The effects of physical training on insulin secretion and effectiveness and on glucose metabolism in obesity and type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 28:881–890CrossRefPubMed
55.
go back to reference Solomon TP, Haus JM, Kelly KR, Rocco M, Kashyap SR, Kirwan JP (2010) Improved pancreatic beta-cell function in type 2 diabetic patients after lifestyle-induced weight loss is related to glucose-dependent insulinotropic polypeptide. Diabetes Care 33:1561–1566CrossRefPubMedPubMedCentral Solomon TP, Haus JM, Kelly KR, Rocco M, Kashyap SR, Kirwan JP (2010) Improved pancreatic beta-cell function in type 2 diabetic patients after lifestyle-induced weight loss is related to glucose-dependent insulinotropic polypeptide. Diabetes Care 33:1561–1566CrossRefPubMedPubMedCentral
56.
go back to reference Dela F, von Linstow ME, Mikines KJ, Galbo H (2004) Physical training may enhance beta-cell function in type 2 diabetes. Am J Phys Endocrinol Metab 287:E1024–E1031CrossRef Dela F, von Linstow ME, Mikines KJ, Galbo H (2004) Physical training may enhance beta-cell function in type 2 diabetes. Am J Phys Endocrinol Metab 287:E1024–E1031CrossRef
Metadata
Title
The effect of different volumes of high-intensity interval training on proinsulin in participants with the metabolic syndrome: a randomised trial
Authors
Joyce S. Ramos
Lance C. Dalleck
Fabio Borrani
Alistair R. Mallard
Bronwyn Clark
Shelley E. Keating
Robert G. Fassett
Jeff S. Coombes
Publication date
01-11-2016
Publisher
Springer Berlin Heidelberg
Published in
Diabetologia / Issue 11/2016
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-016-4064-7

Other articles of this Issue 11/2016

Diabetologia 11/2016 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.